RDNT 82.16 (+2.89%)
US7504911022Medical Diagnostics & ResearchDiagnostics & Research

RadNet (RDNT) Competitor Comparison

We are evaluating the key criteria listed to compare RadNet (RDNT) against its competitors in the Diagnostics & Research industry.

Earnings per Share - RDNT ranking 22 / 56

These are the competitors of RadNet in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
36.42
2. Thermo Fisher Scientific TMO
15.94
3. Medpace Holdings MEDP
11.42
4. Waters WAT
10.46
5. IDEXX Laboratories IDXX
10.35
6. Icon ICLR
8.99
7. Charles River Laboratories CRL
8.01
8. IQVIA Holdings IQV
7.62
9. Quest Diagnostics DGX
7.44
10. Lantheus Holdings LNTH
6.02
11. Danaher DHR
5.29
12. Laboratory Corp of America Holdings LH
5.26
13. Agilent Technologies A
4.8
14. PerkinElmer PKI
2.78
15. DexCom DXCM
1.65
16. National Research NRC
1.12
17. Syneos Health SYNH
0.7
18. Interpace Biosciences IDXG
0.68
19. Global Cord Blood CO
0.59
20. Qiagen QGEN
0.34
21. Sotera Health SHC
0.25
22. RadNet RDNT
0.18
23. Ortho Clinical Diagnostics Holdings OCDX
0
24. Neogen NEOG
-0.11
25. Enzo Biochem ENZ
-0.19
26. Olink Holding OLK
-0.27
27. MaxCyte MXCT
-0.33
28. Biodesix BDSX
-0.38
29. Anixa Biosciences ANIX
-0.39
30. NeoGenomics NEO
-0.61
31. Bioventus BVS
-0.64
32. Psychemedics PMD
-0.79
33. Sera Prognostics SERA
-0.88
34. Neuronetics STIM
-0.89
35. bioAffinity Technologies BIAF
-0.94
36. Exagen XGN
-1.06
37. Exact Sciences EXAS
-1.16
38. Co-Diagnostics CODX
-1.22
39. Aspira Womens Health AWH
-1.41
40. Pacific Biosciences of California PACB
-1.46
41. MDxHealth MDXH
-1.48
42. DarioHealth DRIO
-1.68
43. Myriad Genetics MYGN
-1.74
44. Personalis PSNL
-1.82
45. Heska HSKA
-1.92
46. Organovo Holdings ONVO
-2.16
47. Precipio PRPO
-2.21
48. Natera NTRA
-2.44
49. Trinity Biotech TRIB
-2.57
50. CareDx CDNA
-2.66
51. Prenetics Global PRE
-3.6
52. Twist Bioscience TWST
-3.82
53. Guardant Health GH
-4.28
54. Inotiv NOTV
-4.38
55. Fulgent Genetics FLGT
-4.83
56. Illumina ILMN
-9.98

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.